miR-124-3p inhibits CRC proliferation, migration, and invasion by targeting ITGB1

Jing Li1, Lisi Liu2

  • 1Pediatrics Department, Northeast International Hospital, Shenyang, 110623, China. wojiushilj3278@126.com.

Discover Oncology
|February 11, 2025
PubMed

Insights

MicroRNA-124-3p (miR-124-3p) suppresses colorectal cancer (CRC) growth by targeting ITGB1 and inhibiting the Wnt/β-catenin pathway. This miR-124-3p/ITGB1 axis presents a potential therapeutic target for CRC treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide.
  • MicroRNA-124-3p (miR-124-3p) is recognized as a tumor suppressor in various cancers.
  • Understanding miR-124-3p's role in CRC is crucial for developing new therapeutic strategies.

Purpose of the Study:

  • To investigate the specific functions and molecular mechanisms of miR-124-3p in colorectal cancer cell proliferation, migration, and invasion.
  • To identify potential target genes of miR-124-3p in CRC.
  • To explore the involvement of the Wnt/β-catenin signaling pathway.

Main Methods:

  • Cell proliferation and apoptosis assays (CCK-8, colony formation, flow cytometry).
  • Migration and invasion assays (wound healing).
  • Gene expression analysis (RT-qPCR, Western blotting), bioinformatics analysis, dual-luciferase reporter assays, and rescue experiments.

Main Results:

  • Overexpression of miR-124-3p significantly inhibited CRC cell proliferation and migration, while downregulation promoted these processes.
  • ITGB1 was identified as a direct target of miR-124-3p, with inverse expression correlation.
  • ITGB1 overexpression reversed the inhibitory effects of miR-124-3p on CRC cells and Wnt/β-catenin signaling.

Conclusions:

  • miR-124-3p suppresses colorectal cancer progression by targeting ITGB1.
  • The miR-124-3p/ITGB1 axis regulates CRC cell proliferation and migration, potentially through the Wnt/β-catenin signaling pathway.
  • This axis represents a promising therapeutic target for colorectal cancer treatment.